
Acrow Limited is an Australian engineering and equipment rental company supplying formwork and scaffolding to construction and infrastructure projects. The business generates recurring income from its large hire fleet and has delivered strong revenue growth in recent years. Despite recent share price weakness, it offers solid cash flow and a fully franked dividend yield above 5%.

Orthocell is a regenerative medicine company expanding Remplir globally, but investors remain cautious because revenue growth is uneven, the business is still loss-making, and U.S. uptake may take time, leaving the stock a higher-risk turnaround opportunity.

Dimerix shares plunged 35–40% amid heavy selling and uncertainty around clinical updates, worsened by weak biotech sentiment. Further downside depends on results and the funding outlook, though volatility in early-stage biotech stocks suggests a potential for sharp rebounds.

Acrow (ASX: ACF) is technically rebounding, balancing record revenue and strong industrial-access growth with falling margins and rising debt. Future performance depends on profitably converting its $256 million pipeline and breaking key resistance near $1.00.

Fleetwood Limited (ASX: FWD) is positioning itself as a major player in Australia’s modular construction and accommodation industry. Through its three divisions — Building Solutions, RV Solutions, and Community Solutions — the company has built a resilient, diversified business model capable of navigating cyclical shifts in housing, tourism, and resources.
.webp&w=828&q=75)
Brisbane Broncos (ASX: BBL) is an NRL franchise generating sports entertainment revenue. Its share price volatility stems from on-field performance, low liquidity, and solid earnings growth. Technically, the stock is currently testing key channel support around $1.25.